Immatics (IMTX) Consolidated Net Income (2019 - 2025)

Immatics recorded quarterly Consolidated Net Income of -$46.2 million in Q4 2025, up 22.23% quarter-over-quarter from -$59.4 million in Q3 2025, and down 181.53% year-over-year from $56.6 million in Q4 2024.

Immatics' Consolidated Net Income history runs 7 years deep, the most recent figure standing at -$46.2 million for Q4 2025.

  • In Q4 2025, Consolidated Net Income fell 181.53% year-over-year to -$46.2 million; the TTM figure through Dec 2025 stood at -$231.5 million (down 746.64% YoY), while the FY2025 annual figure was -$226.4 million, down 871.3% from the prior year.
  • Consolidated Net Income came in at -$46.2 million for Q4 2025 at Immatics, up from -$59.4 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $96.1 million in Q1 2022 to a low of -$81.9 million in Q2 2025.
  • A 5-year average of -$17.1 million and a median of -$24.0 million in 2023 frame the typical range for Consolidated Net Income.
  • Across the five-year window, Consolidated Net Income surged 449.38% in 2022 and tumbled 9127.64% in 2025, its largest moves.
  • Immatics' Consolidated Net Income stood at -$19.2 million in 2021, then soared by 129.87% to $5.7 million in 2022, then sank by 590.4% to -$28.1 million in 2023, then surged by 301.35% to $56.6 million in 2024, then plunged by 181.53% to -$46.2 million in 2025.
  • According to Business Quant data, Consolidated Net Income over the past three periods registered -$46.2 million, -$59.4 million, and -$81.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -2.99 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -8.40 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -14.46 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1.03 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -3.40 Mn
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 727.20 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 205.99 Mn
10 Immatics 1.80 Bn 1.80 Bn - -46.18 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -46.18 Mn
Sep 30, 2025 -59.39 Mn
Jun 30, 2025 -81.90 Mn
Mar 31, 2025 -44.01 Mn
Dec 31, 2024 56.65 Mn
Sep 30, 2024 657,833.48
Jun 30, 2024 -19.07 Mn
Mar 31, 2024 -2.43 Mn
Dec 31, 2023 -28.13 Mn
Sep 30, 2023 -28.84 Mn
Jun 30, 2023 -26.80 Mn
Mar 31, 2023 -21.20 Mn
Dec 31, 2022 5.74 Mn
Sep 30, 2022 -19.98 Mn
Jun 30, 2022 -12.47 Mn
Mar 31, 2022 96.14 Mn
Dec 31, 2021 -19.20 Mn
Sep 30, 2021 -32.08 Mn
Jun 30, 2021 -31.95 Mn
Mar 31, 2021 -27.52 Mn
Dec 31, 2020 -21.43 Mn
Sep 30, 2020 -191.51 Mn
Jun 30, 2020 -23.49 Mn
Mar 31, 2020 -9.47 Mn
Dec 31, 2019 -16.53 Mn
Sep 30, 2019 -5.53 Mn
Jun 30, 2019 -7.52 Mn